Rice team rises to big-data breast cancer challenge

October 18, 2013, Rice University
BioWheel, created by the lab of Rice bioengineer Amina Qutub, took top prize in a competition for visualization of "big data" using protein-network data from breast cancer cell lines. The interactive wheel helps researchers track protein expression and drugs used to influence their regulation over time. Credit: Qutub Lab/Rice University

A colorful wheel developed by Rice University bioengineers to visualize protein interactions has won an international competition for novel strategies to study the roots of breast cancer.

The winning BioWheel by the Rice lab of bioengineer Amina Qutub was chosen this week, in the middle of Breast Cancer Awareness Month, topping 14 academic and industry participants in the HPN-DREAM Breast Cancer Network Inference Challenge. Qutub has been invited to present the lab's creation at the RECOMB/ISCB conference on Regulatory and Systems Genomics in Toronto next month.

The Rice team led by graduate student Wendy Hu won one of three subchallenges to create an intuitive, interactive tool to visualize "big data." In this case, that involved hundreds of thousands of data points about the effects of stimulators and inhibitors on networks drawn from a set of four . Team members include postdoctoral researchers Byron Long and Dave Noren and undergraduate student Alex Bisberg.

All of the competitors were presented with the same data set. The idea, according to organizers, was to develop maps that increase the understanding of protein signaling in cancer cells and accelerate the development of treatments. Organizers of the crowdsource-style competition hoped that having dozens of participants work on the same data for four months would produce results that might otherwise take a single group many years.

"The task is to help people interpret intricate patterns that are very hard to see in high-dimensional data," said Qutub, an assistant professor of bioengineering based at Rice's BioScience Research Collaborative. Massive amounts of data can be produced when researchers study how healthy or cancerous cell lines taken from patients respond to stimulants, like drugs that up- or down-regulate protein interactions.

BioWheel, created by the lab of Rice bioengineer Amina Qutub, is intended to help researchers quickly make sense of massive amounts of data. The computer program won a competition to track protein expression in breast cancer cell lines and drugs used to influence their regulation over time. Credit: Qutub Lab/Rice University

"BioWheel visualizes this data in a way that lets people quickly grasp changes in a protein and its connections over time," she said. "If you want to know how sets of proteins in a cancer cell change when you use a particular drug, this allows you to see their relationships quickly."

As presented in the summerlong competition, BioWheel showed connections between proteins and their expression levels as represented in colors that changed from light green (for no expression) to dark red (for high expression) as time progressed from the inside to the outside of the wheel. Shifting connections between proteins on the inner ring are seen in the center.

"The beauty of it is that it's a framework for all kinds of data sets," Qutub said, noting her lab will use BioWheel in an ongoing leukemia project. "We'll look not only at protein levels but also at genetic categories, patient age and gender to see how each parameter affects interactions in the cells."

The Qutub lab experiments on cell lines and builds computer models of protein-signaling networks that trigger such biological processes as cell growth, survival, death and migration. The researchers want to know how these networks operate in to find more effective treatments for patients.

But BioWheel's design doesn't necessarily need to be applied to biological problems, Qutub said. "It could be just as effective to analyze interactions between political parties or links in an Internet network," she said. "It's for big data in general."

The Rice team also placed highly in a second subchallenge to reverse-engineer protein-interaction networks from the same set of cancer-cell , along with a simulated dataset.

Qutub said the organizers are compiling a journal paper for submission and will incorporate BioWheel as part of a software package that will be available to researchers for free through the competition's nonprofit sponsors, Sage Bionetworks and the Dialogue for Reverse Engineering Assessments and Methods (DREAM), a collaboration between Columbia University and IBM.

In the meantime, the lab is working with Rice's Ken Kennedy Institute for Information Technology to continue the development of BioWheel and related network algorithms for compatibility with supercomputing resources, Qutub said.

Explore further: Protein pathways provide clues in leukemia research

Related Stories

Protein pathways provide clues in leukemia research

May 31, 2012
Scientists at Rice University and the University of Texas MD Anderson Cancer Center have successfully profiled protein pathways found to be distinctive to leukemia patients with particular variants of the disease.

Researchers show how blood vessels regroup after stroke

February 11, 2013
Rice scientists simulate "robot" cells to study the development of microvascular systems in the brain. The goal is to find a way to direct the development of vessels that feed oxygen-starved cells in stroke and neurodegenerative ...

Enhanced luminal breast tumor response to antiestrogen therapy

September 3, 2013
Breast cancer can be divided into 4 major subtypes using molecular and genetic information from the tumors. Each subtype is associated with different prognosis and should be taken into consideration when making treatment ...

Why tumors become drug-resistant

August 6, 2013
Cancer drugs known as ErbB inhibitors have shown great success in treating many patients with lung, breast, colon and other types of cancer. However, ErbB drug resistance means that many other patients do not respond, and ...

Light triggers death switch in cancer cells

October 16, 2013
Researchers at Cardiff University have created a peptide (a small piece of protein), linked to a light-responsive dye, capable of switching 'on' death pathways in cancer cells. The peptide remains inactive until exposed to ...

Recommended for you

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.